Sofinnova Investments, Inc. Ikena Oncology, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 382,616 shares of IKNA stock, worth $646,621. This represents 0.04% of its overall portfolio holdings.
Number of Shares
382,616
Previous 115,712
230.66%
Holding current value
$646,621
Previous $164,000
284.76%
% of portfolio
0.04%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
73Shares Held
31.2MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.48 Million1.1% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$8.06 Million0.24% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.91 Million2.8% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.98 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.8 Million4.84% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $61.3M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...